Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Completed 2Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3Pancreatic Neoplasms 2Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Pancreatic Cancer Resectable 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Estrogen Receptor Positive Breast Cancer 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1COVID-19 1Breast Neoplasms, Male 1Breast Neoplasms 1Bone Metastases 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Hydroxychloroquine × Clear all
NCT05221320 2025-09-25

Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies

BioMed Valley Discoveries, Inc

Phase 2 Terminated
47 enrolled 18 charts
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

NCT04381988 2021-10-27

A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated
4 enrolled 5 charts

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡